Author

Meagan E. Grove

Observed name: Meagan Grove

Institutions: Indiana University Health, Indiana University Hospital

Observed institutions: Indiana University Health, Mayo Clinic, Indiana University Hospital, Indiana University Melvin and Bren Simon Comprehensive Cancer Center

OpenAlex ID: A5050997293

Population pharmacokinetics of cefepime in febrile neutropenia: implications for dose-dependent susceptibility and contemporary dosing regimens

2017 · Nathaniel J. Rhodes, Meagan E. Grove, et al. · International Journal of Antimicrobial Agents · 27

QT prolongation in patients with acute leukemia or high-risk myelodysplastic syndrome prescribed antifungal prophylaxis during chemotherapy-induced neutropenia

2019 · Jason N. Barreto, Michael W. Cullen, et al. · Leukemia & lymphoma/Leukemia and lymphoma · 13

Pharmacokinetics of Cefepime in Patients with Cancer and Febrile Neutropenia in the Setting of Hematologic Malignancies or Hematopoeitic Cell Transplantation

2016 · Laura Whited, Meagan Grove, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 13

Precision Genomic Practice in Oncology: Pharmacist Role and Experience in an Ambulatory Care Clinic

2020 · Farah Raheem, Pauline Kim, et al. · Pharmacy · 7

High-Dose Thiotepa-Cyclophosphamide (TT/Cy) Results in Superior Outcomes Compared with Total Body Irradiation-Cyclophosphamide (TBI/Cy) in Patients with Acute Myeloid Leukemia (AML), Advanced Chronic Myeloid Leukemia (CML) and High-Grade Myelodysplasia (MDS) Undergoing Allogeneic Hematopoietic Stem Cell Transplantation (HCT)

2019 · Mustafa A Hyder, Vaibhav Agrawal, et al. · Transplantation and Cellular Therapy · 1

Clinical Oncology Pharmacy Technician: Impact of a New Role on Pharmacy and Patient Metrics at a Large Academic Cancer Center

2024 · Austin Wooten, John Wright, et al. · JCO Oncology Practice

Improved survival for myeloid malignancy patients receiving thiotepa/cyclophosphamide (TT/Cy) versus total body irradiation/cyclophosphamide (TBI/Cy) conditioning and allogeneic stem cell transplantation.

2024 · Cydney Nichols, Kirsten Ervin, et al. · Journal of Clinical Oncology

Thiotepa/cyclophosphamide (TT/Cy) preparative regimen for patients with acute lymphoblastic leukemia (ALL) undergoing allogeneic stem cell transplantation.

2024 · Cydney Nichols, Kirsten Ervin, et al. · Journal of Clinical Oncology

Works count: 8

Citation count: 61

H-index: 4

I10-index: 3